EntityRisk Review: Is PROVEN Right for Biopharma?

EntityRisk’s PROVEN is a business platform for pharmaceutical companies assessing the value and commercial prospects of medicines. It is not a consumer finance or crypto product. The platform is organized into five modules: OutcomesML predicts health outcomes; ValueML models value-based prices, budget impact and cost-effectiveness; EvidenceML links product characteristics and evidence to outcomes; PriceML forecasts likely prices; and CommercialML projects revenue and downside risks across product scenarios.

EntityRisk says the software can combine clinical-trial and real-world data, handle target product profiles, run multiple value frameworks and adapt models across products and geographies. The proposed use is to help teams test pricing and product assumptions, plan evidence generation, and prepare for payer or health-technology assessment discussions. Those are vendor-described capabilities, not a guarantee that a forecast will match real-world outcomes. Ask for a demonstration using a representative use case and clarify what data, model assumptions and expert services your project would require.

EntityRisk does not publish PROVEN’s subscription price, implementation charges or consulting rates. The company invites prospective customers to schedule a meeting, so you should expect to discuss your use case directly rather than choose from a public price list. The product information also does not say whether customers pay per module, user, project or contract term.

Before agreeing to a proposal, request an itemized quote that separates software access from modeling, implementation, data preparation and ongoing support. Ask whether updates, local market adaptations and additional scenarios incur separate charges, and what happens to access and project data when a contract ends. Without published prices or clear package details, you cannot compare the total cost with an in-house modeling workflow or another vendor from the outset. Treat any estimate as specific to the scope and contract you receive, not as a standard rate.

PROVEN is a modeling and analytics product, not a crypto custody service: the described use does not involve depositing tokens or giving EntityRisk control of investment funds. The central trust question is therefore whether its models, handling of sensitive company or research data, and outputs meet your organization’s standards.

EntityRisk says PROVEN includes audit reports and 1,300 automated quality checks intended to identify model errors. Those checks may be relevant to model quality, but they do not establish that the software has undergone an independent cybersecurity audit or that its forecasts are independently validated. The product information does not publish a security audit, licence, data-retention policy or detailed terms for handling customer data. Ask for those documents, information on access controls and data location, and a clear explanation of how assumptions and model changes are recorded. Have your legal, security and health-economics teams review the answers before sharing confidential or patient-level data.

EntityRisk describes PROVEN as a centralized, modular platform with a Python core. It says users can update models with new data and run scenarios in real time, while adapting a common model for different products or geographies. The company also says the software can work with clinical-trial data, real-world data and target product profiles. These descriptions outline the intended workflow, but they do not tell you how the interface works or how quickly a particular project will run.

EntityRisk does not publish supported integrations, deployment options, user roles, onboarding timelines or mobile support. Nor does it offer a public signup flow or self-serve trial in the product information. Ask for a guided demonstration, confirm what technical setup is needed, and test whether your team can inspect assumptions, inputs and outputs in the form your decision-makers require. Confirm whether EntityRisk’s experts are part of onboarding or ongoing use, and whether your staff can maintain models without vendor assistance.

PROVEN is a specialist product for pharmaceutical health economics and commercialization. Its fit depends on whether your organization needs forecasts and analyses in these areas, and whether its methods and workflows match your internal review standards. A general-purpose analytics team, a patient seeking treatment information or an individual crypto user is unlikely to need this platform.

There are also important details to resolve before it can be compared with alternatives: pricing and contract terms are not published, and the product information does not set out security certifications, data protections, integration details or a customer self-service option. EntityRisk describes predictive modeling and quality checks, but that does not remove the need to validate assumptions and scrutinize outputs. If a purchase decision depends on an independently verified security audit, transparent pricing or a trial before a sales discussion, ask EntityRisk directly whether it can meet those requirements. If it cannot, a different vendor may be a better fit.